The development of intraoperative imaging has made it possible to visualize shifting brain structures during surgery, and may allow greater intraoperative discrimination of normal and abnormal tissue. This may provide greater confidence to the neurosurgeon to proceed with a more extensive resection while decreasing postoperative morbidity. We investigated the intraoperative use of a portable CT scanner in the resection of 4 cases of supratentorial, subcortical astrocytomas of childhood to assess its usefulness in determining the endpoint of the dissection. We operated on 4 patients, ages 3–17, with astrocytomas. Three were thalamic, and 1 was based primarily in the caudate nucleus. The approach to the basal ganglia was transcallosal in 3 and transtemporal in 1. Specific observations on the intraoperative use of the portable CT scanner included its overall facility, any additional operative time required, the overall quality of the images, intraoperative decisions made based on the images and problems associated with its use. These observations are presented with a review of intraoperative imaging as it pertains to deep pediatric brain tumors. The CT scanner was helpful in limiting the dissection of the hypothalamic and midbrain regions and in localizing remaining abnormal tissue. The scans allowed informed decisions about leaving margins of the tumor which were adjacent to vital structures, but dit not prove to be a decisive factor in providing a complete resection. The following observations are worth noting: (1) average imaging time was 20 min per scan; (2) the extent and location of residual enhancing tumor was easily identified despite other materials in the surgical bed; (3) air/tissue interfaces limit resolution; (4) tumors retain contrast long enough to obtain multiple scans without additional dye, and (5) the cost profile of a mobile CT scanner is superior to that of a fixed intraoperative CT scanner.

1.
Arseni C: Tumors of the basal ganglia. Arch Neurol Psychiatry 1958;80:18–24.
2.
McKissock W, Paine KWE: Primary tumors of the thalamus. Brain 1958;81:41–63.
3.
Torkildsen A: Should extirpation be attempted in cases of neoplasm in or near the third ventricle of the brain? Experiences with a pallative method. J Neurosurg 1948;5:249–275.
4.
Ward A, Spurling G: The conservative treatment of third ventricle tumors. J Neurosurg 1948;5:124–130.
5.
Ojemann G, Ojemann J, Lettich E, Berger M: Cortical language localization in left, dominant hemisphere. An electrical stimulation mapping investigation in 117 patients. J Neurosurg 1989;71:316–326.
6.
Berger MS, Kincaid J, Ojemann GA, Lettich E: Brain mapping techniques to maximize resection, safety, and seizure control in children with brain tumors. Neurosurgery 1989;25:786–792.
7.
Berger MS, Ojemann GA, Lettich E: Neurophysiological monitoring during astrocytoma surgery. Neurosurg Clin North Am 1990;1:65–80.
8.
Heiskanen O: Intracranial tumors of children. Childs Brain 1977;3:69–78.
9.
King RB, Schell GR: Cortical localization and monitoring during cerebral operations. J Neurosurg 1987;67:210–219.
10.
Rubin JM, Mirfakhraee M, Duda EE, Dohrmann GJ, Brown F: Intraoperative ultrasound examination of the brain. Radiology 1980;137:831–832.
11.
Gooding GA, Boggan JE, Weinstein PR: Characterization of intracranial neoplasms by CT and intraoperative sonography. Am J Neuroradiol 1984;5:517–520.
12.
LeRoux PD, Berger MS, Ojemann GA, Wang K, Mack LA: Correlation of intraoperative ultrasound tumor volumes and margins with preoperative computerized tomography scans. An intraoperative method to enhance tumor resection. J Neurosurg 1989;71:691–698.
13.
Hammoud MA, Ligon BL, elSouki R, Shi WM, Schomer DF, Sawaya R: Use of intraoperative ultrasound for localizing tumors and determining the extent of resection: A comparative study with magnetic resonance imaging. J Neurosurg 1996;84:737–741.
14.
Poon WS, Schomacker KT, Deutsch TF, Martuza RL: Laser-induced fluorescence: Experimental intraoperative delineation of tumor resection margins. J Neurosurg 1992;76:679–686.
15.
Haglund MM, Hochman DW, Spence AM, Berger MS: Enhanced optical imaging of rat gliomas and tumor margins. Neurosurgery 1994;35:930–940; discussion 940–941.
16.
Haglund MM, Berger MS, Hochman DW: Enhanced optical imaging of human gliomas and tumor margins. Neurosurgery 1996;38:308–317.
17.
Boppart SA, Brezinski ME, Pitris C, Fujimoto JG: Optical coherence tomography for neurosurgical imaging of human intracortical melanoma. Neurosurgery 1998;43:834–841.
18.
Black PM, Moriarty T, Alexander E III, Stieg P, Woodard EJ, Gleason PL, Martin CH, Kikinis R, Schwartz RB, Jolesz FA: Development and implementation of intraoperative magnetic resonance imaging and its neurosurgical applications. Neurosurgery 1997;41:831–842; discussion 842–845.
19.
Hall WA, Martin AJ, Liu H, Pozza CH, Casey SO, Michel E, Nussbaum ES, Maxwell RE, Truwit CL: High-field strength interventional magnetic resonance imaging for pediatric neurosurgery. Pediatr Neurosurg 1998;29:253–259.
20.
Shalit MN, Israeli Y, Matz S, Cohen ML: Intra-operative computerized axial tomography. Surg Neurol 1979;11:382–384.
21.
Shalit MN, Israeli Y, Matz S, Cohen ML: Experience with intraoperative CT scanning in brain tumors. Surg Neurol 1982;17:376–382.
22.
Lunsford LD: A dedicated CT system for the stereotactic operating room. Appl Neurophysiol 1982;45:374–378.
23.
Perry JH, Rosenbaum AE, Lunsford LD, Swink CA, Zorub DS: Computed tomography/guided stereotactic surgery: Conception and development of a new stereotactic methodology. Neurosurgery 1980;7:376–381.
24.
Engle DJ, Lunsford LD: Brain tumor resection guided by intraoperative computed tomography. J Neurooncol 1987;4:361–370.
25.
Kabuto M, Kubota T, Kobayashi H, Handa Y, Sato K, Ishii H, Takeuchi H, Uno H, Arishima H, Ido K, Ueda Y, Adachi M, Ishida M, Hasegawa Y, Yanagimoto M, Goto Y: Intraoperative CT imaging system using a mobile CT scanner gantry mounted on floor-embedded rails for neurosurgery. No To Shinkei 1998;50:1003–1008.
26.
Butler WE, Piaggio CM, Constantinou C, Niklason L, Gonzalez RG, Cosgrove GR, Zervas NT: A mobile computed tomographic scanner with intraoperative and intensive care unit applications. Neurosurgery 1998;42:1304–1310; discussion 1310–1311.
27.
Okudera H, Kobayashi S, Kyoshima K, Gibo H, Takemae T, Sugita K: Development of the operating computerized tomographic scanner system for neurosurgery. Acta Neurochir 1991;111:61–63.
28.
Pollack IF, Albright AL, Adelson PD, Fitz CR: The role of frameless stereotactic techniques in the treatment of pediatric CNS lesions. Pediatr Neurol 1995;13:209–216.
29.
Berger MS: The impact of technical adjuncts in the surgical management of cerebral hemispheric low-grade gliomas of childhood. J Neurooncol 1996;28:129–155.
30.
Roberts DW, Hartov A, Kennedy FE, Miga MI, Paulsen KD: Intraoperative brain shift and deformation: A quantitative analysis of cortical displacement in 28 cases. Neurosurgery 1998;43:749–758; discussion 758–760.
31.
Hata N, Dohi T, Iseki H, Takakura K: Development of a frameless and armless stereotactic neuronavigation system with ultrasonographic registration. Neurosurgery 1997;41:608–613; discussion 613–614.
32.
Jodicke A, Deinsberger W, Erbe H, Kriete A, Boker DK: Intraoperative three-dimensional ultrasonography: An approach to register brain shift using multidimensional image processing. Minim Invasive Neurosurg 1998;41:13–19.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.